Kamada Announces Planned Transition of Chief Financial Officer
Kamada Ltd., a global biopharmaceutical company specializing in specialty plasma-derived therapies, announced that CFO Chaime Orlev will step down on December 31, 2026, to pursue other opportunities. The company is conducting a search for his successor and expects a seamless transition. Kamada continues to focus on growth driven by its commercial p…